Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Clinical trial NCT01678963 · COMPLETED
Trial details
- NCT number
- NCT01678963
- Sponsor
- Ohr Pharmaceutical Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-03-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.